Exercise of Warrants

In brief · summary, not quotable

MedPal AI plc has announced the exercise of warrants for 4,130,833 new ordinary shares at an exercise price of 4 pence per share, raising £165,233.32 for the company. These new shares are expected to be admitted to trading on AIM around September 17, 2026, and will rank equally with existing shares. Following this, the company's total issued share capital will be 783,249,135 ordinary shares.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your MPAL notes

MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-powered, integrated digital health and pharmacy company, announces that the Company has received a notice to exercise warrants over a total of 4,130,833 new ordinary shares of 0.0002 pence each in the Company at an exercise price of 4 pence per share ("Warrant Shares"), raising £165,233.32 for the Company.

ADMISSION AND TOTAL VOTING RIGHTS

Application will be made for the 4,130,833 Warrant Shares to be admitted to trading on AIM which is expected to occur on or around 17 September 2026 ("Admission"). The Warrant Shares will rank pari passu in all respects with the ordinary shares of the Company currently traded on AIM.

Following Admission, the Company's issued share capital will comprise 783,249,135 ordinary shares of 0.0002p each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.